Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial

Journal of Diabetes

Volumn 10, Issue 5, 2018, Pages 386-397

  Ranasinghe, Priyanga ^a   Wathurapatha, Wasundara S ^a   Galappatthy, Priyadarshani ^a   Katulanda, Prasad ^a   Jayawardena, Ranil ^a,b   Constantine, Godwin R ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

blood glucose; insulin resistance; prediabetes; zinc supplementation

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ZINC; BIOLOGICAL MARKER; INSULIN; LIPID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY COMPLIANCE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ZINC DEFICIENCY; AGED; BLOOD; CLINICAL TRIAL; COMPLICATION; DIETARY SUPPLEMENT; DISEASE EXACERBATION; DRUG EFFECT; GLUCOSE TOLERANCE TEST; HEALTH STATUS; METABOLISM; PHASE 2 CLINICAL TRIAL; RISK FACTOR; SRI LANKA; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH STATUS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS; SRI LANKA; TIME FACTORS; TREATMENT OUTCOME; ZINC;

EID: 85045258663     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12621     Document Type: Article

References (36)

1. International Diabetes Federation. About Diabetes: Facts and Figures. 2017. Available from: http://www.idf.org/about-diabetes/facts-figures (accessed 14 April 2017).
2. Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015; 6: 850–867.
3. Edwards CM, Cusi K. Prediabetes: A worldwide epidemic. Endocrinol Metab Clin North Am. 2016; 45: 751–764.
4. International Diabetes Federation (IDF). IDF Diabetes Atlas. IDF, Brussels, 2011.
5. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: A high-risk state for diabetes development. Lancet. 2012; 379: 2279–2290.
6. King JC, Cousins RJ. Zinc. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ (eds). Modern Nutrition in Health and Disease, 10th edn. Lippincott Williams and Wilkins, Philadelphia, 2006; 271–285.
7. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr. 1998; 17: 109–115.
8. Pidduck HG, Wren PJ, Evans DA. Hyperzincuria of diabetes mellitus and possible genetical implications of this observation. Diabetes. 1970; 19: 240–247.
9. Garg VK, Gupta R, Goyal RK. Hypozincemia in diabetes mellitus. J Assoc Physicians India. 1994; 42: 720–721.
10. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983; 75: 273–277.
11. Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P. Effects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis. Diabetol Metab Syndr. 2012; 4: 13.
12. Islam MR, Arslan I, Attia J et al. Is serum zinc level associated with prediabetes and diabetes? A cross-sectional study from Bangladesh. PLoS One. 2013; 8: e61776.
13. Vashum KP, McEvoy M, Shi Z et al. Is dietary zinc protective for type 2 diabetes? Results from the Australian longitudinal study on women’s health. BMC Endocrine Disorders. 2013; 13: 40.
14. Marreiro DN, Geloneze B, Tambascia MA, Lerário AC, Halpern A, SMF C. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006; 112: 109–118.
15. Hashemipour M, Kelishadi R, Shapouri J et al. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens). 2009; 8: 279–285.
16. Islam MR, Attia J, Ali L et al. Zinc supplementation for improving glucose handling in pre-diabetes: A double blind randomized placebo controlled pilot study. Diabetes Res Clin Pract. 2016; 115: 39–46.
17. Ranasinghe P, Jayawardena R, Pigera AS, Katulanda P, Constantine GR, Galappaththy P. Zinc supplementation in pre-diabetes: Study protocol for a randomized controlled trial. Trials. 2013; 14: 52.
18. World Health Organization (WHO), International Diabetes Federation (IDF). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. 2006. Available at: http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf (accessed 28 November 2017).
19. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC. The effect of oral antidiabetic agents on A1C levels: A systematic review and meta-analysis. Diabetes Care. 2010; 33: 1859–1864.
20. Katulanda P, Constantine GR, Mahesh JG et al. Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka – Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med. 2008; 25: 1062–1069.
21. Doig GS, Simpson F. Randomization and allocation concealment: A practical guide for researchers. J Crit Care. 2005; 20: 187–191.
22. World Health Organization (WHO). Report of a WHO Expert Committee: Physical status: The use and interpretation of anthropometry. World Health Organ Tech Rep Ser. 1995; 854: 427–431.
23. Jayawardena R, Swaminathan S, Byrne NM, Soares MJ, Katulanda P, Hills AP. Development of a food frequency questionnaire for Sri Lankan adults. Nutr J. 2012; 11: 63.
24. Katulanda P, Jayawardena R, Ranasinghe P, Rezvi Sheriff MH, Matthews DR. Physical activity patterns and correlates among adults from a developing country: The Sri Lanka Diabetes and Cardiovascular Study. Public Health Nutr. 2013; 16: 1684–1692.
25. Lustgarten JA, Wenk RE. Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem. 1972; 18: 1419–1422.
26. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998; 21: 2191–2192.
27. Saharia GK, Goswami RK. Evaluation of serum zinc status and glycated hemoglobin of type 2 diabetes mellitus patients in a tertiary care hospital of Assam. J Lab Physicians. 2013; 5: 30–33.
28. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006; 20: 3–18.
29. Institute of Medicine Food and Nutrition Board. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academies Press, Washington DC, 2001.
30. 2+-transporter-8: A dual role in diabetes. BioFactors. 2009; 35: 356–363.
31. Brender JR, Hartman K, Nanga RPR et al. Role of zinc in human islet amyloid polypeptide aggregation. J Am Chem Soc. 2010; 132: 8973–8983.
32. 2+ in pancreatic alpha-cells. J Biol Chem. 2008; 283: 10184–10197.
33. Ranasinghe P, Pigera S, Galappatthy P, Katulanda P, Constantine GR. Zinc and diabetes mellitus: Understanding molecular mechanisms and clinical implications. Daru. 2015; 23: 44.
34. Guerrero-Romero F, Rodriguez-Moran M. Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: A 15-year follow-up study. Eur J Intern Med. 2014; 25: 265–269.
35. Ranasinghe P, Wathurapatha WS, Ishara MH et al. Effects of zinc supplementation on serum lipids: A systematic review and meta-analysis. Nutr Metab (Lond). 2015; 12: 26.
36. Superko HR. Beyond LDL cholesterol reduction. Circulation. 1996; 94: 2351–2354.